Table S3.
Parameter | B | Standard error | t | Significance |
---|---|---|---|---|
Intercept | −7.271 | 2.162 | −3.363 | 0.001 |
Age | 0.026 | 0.033 | 0.789 | 0.432 |
Gender | ||||
Male | 0.425 | 0.622 | 0.684 | 0.496 |
Female | 0a | |||
Inhaled corticosteroids | ||||
Inhaled corticosteroid use | 0.108 | 0.807 | 0.134 | 0.893 |
No inhaled corticosteroid use | 0a | |||
Smoking status | ||||
Yes | 1.339 | 0.585 | 2.289 | 0.025 |
No (ex-smoker or never-smoker) | 0a | |||
COPD status | ||||
COPD III–IV | 4.069 | 1.211 | 3.359 | 0.001 |
COPD II | 2.140 | 0.664 | 3.223 | 0.002 |
Without COPD | 0a |
Notes:
Reference parameter is set to 0. Linear regression analysis, where the natural logarithm of the protein expression of BPIFA1 is designated as the dependent variable; gender as a fixed factor; COPD status, smoking status, and inhaled corticosteroids as random factors; and age as a covariate.
Abbreviation: COPD, chronic obstructive pulmonary disease.